Answers are grounded in this paper and cite their sources.
Aims Endoscopic retrograde cholangiopancreatography (ERCP) routinely used as an inpatient procedure, due to post-procedural complications [ 1 ] [ 2 ]. The inpatient setting allows close observation but also increases healthcare costs and may not be necessary for all patients [ 1 ]). Improved procedural safety, sedation practices, and early recovery protocols have raised the possibility of performing ERCP on an outpatient or ambulatory basis, allowing same-day discharge [ 3 ]. The present study aimed to evaluate the feasibility and safety outcomes of ambulatory ERCP performed in a tertiary referral center. Methods A retrospective study of consecutive ERCP between June 2019 and October 2025 was performed. Safety was defined as the presence of early adverse events (≤72 hours). Adverse events were categorized as minor and serious. The latter included those that required new hospitalization after discharge (outpatients) or prolonged hospitalization (inpatients). Feasibility was defined as successful same-day discharge without unplanned admission or observation≥24 hours. Ambulatory patients followed the center's local protocol and were advised to immediately report if pain, bleeding, dizziness, nausea, vomiting, or any alarm symtom arised. Results A total of 6000 ERCPs were performed from 2019 to 2025. 1000 patients were randomly selected and reviewed, and 206 were excluded from the analysis. A total of 794 patients were enrolled and distributed into outpatient [382/794 (48,1%)] and inpatients [423/794 (53.2%)]. Overall median age was 54.0 (35 – 68) (p=.005) and 54.9% were female (p=.267). Previous ERCP procedures were more common in the outpatient group (20.7% vs 10.7%, p<.001), previous cholecystectomy was most common in the outpatient group (31.2% vs 23.3%, p>.05) (Table 1). The most common ERCP indication was choledocholithiasis in the outpatient (74.9%) and inpatient (65.3%) groups, followed by tumor suspicion in the outpatient group (16.0%) and biliary sludge in the inpatient group (18.9%). Difficult cannulation in the outpatient and inpatient groups was 7.6% and 7.0%, respectively (p=.764). Sphincterotomy was performed in 90.8% of outpatient and 92.0% of inpatient, respectively (p=.562), and biliary stenting was reported in 28.3% and 24.5%, respectively (p=.229). Complication rate was similar among groups with 14.4% in the outpatient and 9.7% in the inpatient group (p>.05). Bleeding was the most common adverse, being mild in forty-two outpatient cases (11.0%) and 28 inpatient cases (7.0%), managed with sclerotherapy; however, 2 cases in outpatient and 1 case in the inpatient group required hospitalization. A sub-analysis was conducted considering the serious adverse events that required hospitalization after discharge or extended hospital stay. There were 13 cases among the outpatients who required a new hospitalization after discharge, and 12 inpatients who required prolonged hospital stay (p>.05). Post-ERCP pancreatitis was higher in the outpatient groups (2.4%), compared to 2.2% of inpatients (p>.05). Most inpatient cases achieved technical success (99.5%, p<.001) and less clinical success (88.8%, p<.001), compared to outpatient's (86.4% and 93.7%), respectively. No mortality was perceived in either group. Conclusions Ambulatory ERCP proved to be a feasible and safe strategy, with complication and serious adverse event rates comparable to those of inpatient ERCP. Most adverse events were mild, and only a small proportion of patients required hospitalization or extended observation. Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
No takes yet. Share an insight, caveat, or question.
Robles-Medranda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: